LAVA Therapeutics NV (LVTX) — Free Cash Flow Generation Index

Latest as of December 2022: 0.99x

LAVA Therapeutics NV (LVTX) has a Free Cash Flow Generation Index of 0.99x as of December 2022. Free cash flow of $35.47 Million represents 1% of operating cash flow ($35.73 Million). Read LAVA Therapeutics NV balance sheet liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

0.99x
Free Cash Flow / Operating CF

Free Cash Flow

$35.47 Million
USD

Operating Cash Flow

$35.73 Million
USD

Capital Expenditures

$265.00K
USD

LAVA Therapeutics NV Free Cash Flow Generation Index (2022–2022)

Historical FCF Generation Index trend for LAVA Therapeutics NV across 1 annual periods. Explore LAVA Therapeutics NV (LVTX) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for LAVA Therapeutics NV (2022–2022)

Year-by-year Free Cash Flow Generation Index for LAVA Therapeutics NV. For the full company profile including market capitalisation, see LVTX market cap overview.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2022 0.85x $3.46 Million $4.04 Million $587.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).